Literature DB >> 21183182

Eosinophil cationic protein and clinical outcome after bare metal stent implantation.

Giampaolo Niccoli1, Gregory A Sgueglia, Micaela Conte, Nicola Cosentino, Silvia Minelli, Flavia Belloni, Carlo Trani, Vito Sabato, Francesco Burzotta, Italo Porto, Antonio Maria Leone, Domenico Schiavino, Filippo Crea.   

Abstract

OBJECTIVE: we assessed the association between baseline eosinophil cationic protein (ECP) levels, a sensitive marker of eosinophil activation, and clinical outcome in patients undergoing bare metal stent (BMS) implantation.
METHODS: basal ECP levels were measured in 110 patients (69±11 years, 88 men) undergoing BMS implantation. Major adverse cardiac events (MACEs), defined as cardiac death, non-fatal myocardial infarction, or clinically-driven target lesion revascularization, were registered at 24-month follow-up.
RESULTS: eighteen (16.4%) patients had MACEs and showed higher ECP levels compared with those without MACEs [20.1 (9.8-47.3) vs. 9.5 (5.0-27.2) g/L, p=0.02]. At follow-up, ECP level>11 g/L was the only significant predictor of MACEs (HR 3.5, 95% CI 1.1-10.4, p=0.03).
CONCLUSION: basal ECP levels are associated with MACEs after BMS implantation, suggesting that an allergic-mediated inflammation against the metal could explain some adverse reactions occurring after coronary stenting.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21183182     DOI: 10.1016/j.atherosclerosis.2010.11.044

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  6 in total

Review 1.  Interaction between allergic asthma and atherosclerosis.

Authors:  Cong-Lin Liu; Jin-Ying Zhang; Guo-Ping Shi
Journal:  Transl Res       Date:  2015-10-09       Impact factor: 7.012

Review 2.  Regulation of Type 2 Immunity in Myocardial Infarction.

Authors:  Jun-Yan Xu; Yu-Yan Xiong; Xiao-Tong Lu; Yue-Jin Yang
Journal:  Front Immunol       Date:  2019-01-29       Impact factor: 7.561

Review 3.  Pathogenesis and Clinical Significance of In-Stent Restenosis in Patients with Diabetes.

Authors:  Grzegorz K Jakubiak; Natalia Pawlas; Grzegorz Cieślar; Agata Stanek
Journal:  Int J Environ Res Public Health       Date:  2021-11-15       Impact factor: 3.390

Review 4.  Hypersensitivity and in-stent restenosis in coronary stent materials.

Authors:  Wansong Hu; Jun Jiang
Journal:  Front Bioeng Biotechnol       Date:  2022-09-15

5.  What is the clinical benefit of neutrophil-lymphocyte ratio in cardiovascular patients?

Authors:  Yavuzer Koza
Journal:  J Cardiovasc Thorac Res       Date:  2014-06-30

Review 6.  Current Understanding of the Immunomodulatory Activities of High-Density Lipoproteins.

Authors:  Athina Trakaki; Gunther Marsche
Journal:  Biomedicines       Date:  2021-05-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.